
    
      A multicentre, double blind, placebo controlled trial to assess efficacy of VEGF and promote
      myocardial angiogenesis in patients with CCS III-IV angina symptoms,treated with maximal anti
      anginal medications who are not amenable to or not ideal candidates for conventional
      revascularization.
    
  